It has not been previously associated with NAFLD; however, it is connected to three human NAFLD GWAS genes (GCKR, LYPLAL1, and TM6SF2) in our liver network, making it a strong novel candidate target for NAFLD. Here, GCKR is linked to metabolic dysfunction-associated steatotic liver disease.